why are there so many glp 1 drugs GLP-1 Why do obesity drugs seem

The New England Journal of Medicine, 387 (24), 22452257

P., Geiss, L

We used Stata to create a network diagram and ranked GLP-1RAs with different doses based on the surface under the cumulative ranking curve (SUCRA) to evaluate their efficacy of type 2 diabetes

Introduction Type 2 diabetes mellitus (T2DM) and gestational diabetes mellitus (GDM) are growing challenges worldwide, including in India, where prevalence rates are steadily rising

In this regard, it is noteworthy that metformin increases intestinal glucose utilisation [3], which perhaps could be coupled to GLP-1 production

The dipeptidyl peptidase-4 inhibitor des-fluoro-sitagliptin regulates brown adipose tissue uncoupling protein levels in mice with diet-induced obesity